• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Janssen ’s Save Legs. Change Lives.™ is Creating a More Equitable Future for Communities at Risk of PAD-Related Amputations
TITUSVILLE, NJ, November 4, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the first impact summary for its Save Legs. Change Lives.™ Spot Peripheral Artery Disease Now multi-year initiative, designed to create urgency and action around the hidden threat of peripheral artery disease (PAD)-related amputation. In its inaugural year, Save Legs. Change Lives.™ focused on reaching Black Americans, who are up to four times more likely than white Americans to have a PAD-related amputation.1 With this critical initiative, Janssen is focused on helping those at risk of PAD through more th...
Source: Johnson and Johnson - November 4, 2022 Category: Pharmaceuticals Tags: Latest News Source Type: news

New Analyses Suggest Favorable Results for STELARA ® (ustekinumab) When Used as a First-Line Therapy for Bio-Naïve Patients with Moderately to Severely Active Crohn’s Disease and Ulcerative Colitis
SPRING HOUSE, PENNSYLVANIA, October 25, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced data from two new analyses of STELARA® (ustekinumab) for the treatment of adults with moderately to severely active Crohn’s disease (CD) and ulcerative colitis (UC).1,2 In a modelled analysisa focused on treatment sequencing using data from randomized controlled trials, network meta-analysis and literature, results showed patient time spent in clinical remission or response was highest when STELARA was used as a first-line advanced therapy for bio-naïve patients with moderately to severely acti...
Source: Johnson and Johnson - October 25, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Home-Based Telerehabilitation Beneficial for Stroke Patients
THURSDAY, Oct. 1, 2020 -- Home-based motor training telerehabilitation is beneficial for stroke patients, with enhanced interhemispheric functional connectivity of the M1 areas, according to a study published online Sept. 30 in Neurology. Jing...
Source: Drugs.com - Pharma News - October 1, 2020 Category: Pharmaceuticals Source Type: news

High-Intensity Training Improves Walking in Stroke Survivors
THURSDAY, Aug. 29, 2019 -- High-intensity stepping training that mimics real-world conditions may better improve walking ability in stroke survivors, according to a study published in the September issue of Stroke. T. George Hornby, Ph.D., P.T.,...
Source: Drugs.com - Pharma News - August 29, 2019 Category: Pharmaceuticals Source Type: news

Myoelectric Computer Interface Beneficial for Stroke Survivors
THURSDAY, April 11, 2019 -- A myoelectric computer interface (MyoCI) training paradigm that provides intuitive feedback about muscle activation patterns is well tolerated and can reduce abnormal coactivation among stroke survivors, according to a...
Source: Drugs.com - Pharma News - April 11, 2019 Category: Pharmaceuticals Source Type: news

Pali Momi Medical Center opens simulation education lab
Pali Momi Medical Center opened its new simulation education lab on Thursday, the first of its kind in Central and West Oahu. The Hawaii Pacific Health Center for Simulation and Education features high-tech manikins, equipment and classroom space to support education and training for the hospital’s health care professionals.  “As the only level III trauma center and primary stroke center in Central and West Oahu, P ali Momi Medical Center serves as a safety net for the residents on this side…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - December 27, 2018 Category: Pharmaceuticals Authors: Anna Hrushka Source Type: news

Silk Road Medical Appoints World Class Stroke Prevention Champion to Serve as Vice President, Medical Affairs and Professional Education
Tammy Leitsinger to spearhead global physician education and peer-to-peer training for rapidly growing Trans Carotid Artery Revascularization (TCAR) procedure SUNNYVALE, Calif., Oct. 11, 2017 -- (Healthcare Sales & Marketing Network) -- Silk Road Medic... Devices, Neurology, Personnel Silk Road Medical, ENROUTE, TransCarotid Artery Revascularization, stroke
Source: HSMN NewsFeed - October 11, 2017 Category: Pharmaceuticals Source Type: news

Legacy's new device helps stroke patients get on their feet sooner (Video)
Gary LaRue, a 74-year-old Yamhill County farmer, had a severe stroke on March 17 that paralyzed his right side and affected his speech. Less than six weeks later, he was walking — with assistance — thanks to a new device at the Legacy Rehabilitation Institute of Oregon, or RIO, which is located at Legacy Good Samaritan Medical Center in Portland. The institute is the first in the Pacific Northwest to offer the ZeroG Gait and Balance Training System, a robotic mechanism that helps brain and…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 25, 2016 Category: Pharmaceuticals Authors: Elizabeth Hayes Source Type: news

Saint Luke's will build new rehab hospital in KC
Saint Luke's Health System announced Tuesday it plans to build a freestanding inpatient rehabilitation hospital in Kansas City. The hospital has not selected a location, but said it plans to open a more than 60,000-square-foot hospital with 60 beds. The rehabilitation hospital will include a dedicated stroke unit, brain injury unit, specially equipped rooms for bariatric patients, pet therapy and an outdoor healing garden. It will also including a training apartment where patients and their families…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - June 17, 2014 Category: Pharmaceuticals Authors: Brianne Pfannenstiel Source Type: research

Ninds
InitiativeThe mission of the National Institute of Neurological Disorders and Stroke (NINDS) is to seek fundamental knowledge about the brain and nervous system and to use that knowledge to reduce the burden of neurological disease. To support this mission, NINDS: Supports and performs basic, translational, and clinical neuroscience research through grants-in-aid, contracts, scientific meetings, and through research in its own laboratories, and clinics. Funds and conducts research training and career development programs to increase basic, translational and clinical neuroscience expertise and ensure a vibrant, talented, a...
Source: PHRMA - March 28, 2014 Category: Pharmaceuticals Authors: Julie Source Type: news

Gabriela Lavezzari
AVP, Scientific Affairs Gabriela Lavezzari, Ph.D., M.B.A. joined PhRMA in July 2012 as Assistant Vice President, Scientific Affairs. In this role, Dr. Lavezzari is the primary staff lead for a variety of strategic initiatives aimed at establishing PhRMA as a valuable source of scientific expertise in innovative biopharmaceutical research and development within the Scientific & Regulatory Affairs (S&RA) division of PhRMA.  Dr. Lavezzari brings to PhRMA over ten years of combined research experience in the government and industry, with multi-disciplinary expertise in Personalized Medicine and Regulatory Science. Pri...
Source: PHRMA - March 27, 2014 Category: Pharmaceuticals Authors: Julie Source Type: news

Diane Stephenson, Ph.D.
EVP, Coalition Against Major DiseasesDiane Stephenson is a neuroscientist by training with 30 years  combined experience in academic neuroscience and drug discovery.  She is passionate about translational science and has a long time  dedication to the discovery of therapies to treat diseases of the nervous system. Diane received her undergraduate degree in Biochemistry at University of California, Santa Barbara and her Ph.D. in Medical Neurobiology from Indiana University. In her academic career, Diane focused her research on Amyotrophic Lateral Sclerosis and Alzheimer's disease while in industry she focused on drug dis...
Source: PHRMA - November 5, 2013 Category: Pharmaceuticals Authors: Leah Source Type: news

Diane Stephenson
is a neuroscientist by training with 30 years  combined experience in academic neuroscience and drug discovery.  She is passionate about translational science and has a long time  dedication to the discovery of therapies to treat diseases of the nervous system. Diane received her undergraduate degree in Biochemistry at University of California, Santa Barbara and her Ph.D. in Medical Neurobiology from Indiana University. In her academic career, Diane focused her research on Amyotrophic Lateral Sclerosis and Alzheimer's disease while in industry she focused on drug discovery for Alzheimer's disease, stroke and Parkinson'...
Source: PHRMA - November 5, 2013 Category: Pharmaceuticals Authors: Leah Source Type: news

If you could propose one idea to help improve health care delivery in the United States, what would it be?
Thumbnail: Tags: conversationsphrma conversationslarry hausnermyrl weinbergchris hansennancy brownContributors: 11621161115911631173Contributions: Read Larry Hausner's bio Despite the rapid development of innovative technologies in the health care field, we have yet to discover a panacea that will easily transform our health care system into one that provides high-quality and cost-effective care.  What we have discovered and come to agree on over the last decade is that our sick care system must be reconfigured to a health care system that emphasizes wellness and prevention.  For that reason, I offer ...
Source: PHRMA - June 24, 2013 Category: Pharmaceuticals Authors: rlowe Source Type: news